Refractive Surgery News

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Jay S. Pepose, MD, PhD, shares an update on some of the ophthalmic agents that Ocuphire Pharma has in the pipeline.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Robert E. Ang, MD, discusses results from a study of laser scleral microporation.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Bret L. Fisher, MD, discusses the mechanism of action for a small-aperture IOL.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, George O. Waring IV, MD, FACS, discusses the advantages of the STAAR Surgical EVO Visian ICL for the treatment of myopia and myopic astigmatism.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Daniel H. Chang, MD, discusses the effect of violet light filtration on extended depth of focus IOL performance.

Nyxol demonstrated positive topline results in subjects with night vision disturbances in the phase 3 LYNX-1 pivotal clinical trial, Ocuphire Pharma announced in a press release.

DENVER — In this Healio Video Perspective from the ARVO meeting, Daniel H. Chang, MD, discusses his virtual poster on the duration of Vuity (Allergan) in photopic intermediate visual acuity.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Mark C. Lobanoff, MD, discusses a study he conducted on visual acuity results from topography-guided LASIK treatments.

Nyxol demonstrated positive results in a pediatric safety trial to reverse pharmacologically induced mydriasis, according to a press release from Ocuphire Pharma.

More options are on the way to treat patients with presbyopia, according to a presentation at Real World Ophthalmology.